Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma - Amato,D.A.; Borden,E.C.; Shiraki,M.; Enterline,H.AT.; Rosenbaum,C.; Davis,H.L.; Paul,A.R.; Stevens,C.M.; Lerner,H.J. (Investigational New Drugs, 1985)